Key points
- The Multi-Vaccine Vaccine Information Statement (VIS) was created with the earliest pediatric visits (birth through 6 months) in mind.
- A child may get up to 6 vaccinations during a visit. The Multi-Vaccine VIS simplifies the process by streamlining information into one VIS document.
- These answers should help providers respond to parents' common questions.
Background
This page addresses questions and answers concerning use of the “Multi-Vaccine VIS.” If you have a question about this document that is not answered here, please contact us.
Frequently Asked Questions
A: It was developed with the earliest pediatric visits (i.e., birth through 6 months) in mind. Up to 6 vaccinations could be given during these visits, meaning (for the provider) that 6 individual VISs would have to be downloaded, printed and distributed and (for the patient) 6 documents would have to be read, containing much information that is duplicated. The multi-vaccine VIS is an effort to simplify and streamline this process.
A: Yes. The Multi-Vaccine VIS is an optional alternative to existing VISs. Providers wishing to continue using the individual VISs may do so. These will continue to be updated when recommendations change, as they have always been.
A: No. Any time two or more of the vaccines are given together, it makes sense to use the Multi-Vaccine VIS. The provider should check the appropriate boxes on the first page, corresponding to vaccines given during that visit.
A: Yes. It gives the parents a written record of which vaccines were administered.
A: Yes. Just check the appropriate boxes as you would if you were administrating the individual vaccines.
A: If you use the Multi-Vaccine VIS, record its date for each of the vaccines given that day. If there is ever a question, this will make it clear that the Multi-Vaccine VIS was used and not the individual VISs.
A: It may be used for older children getting two or more of these vaccines during the same visit (e.g., a 12-month old getting Hib and PCV, or a 4-year old getting DTaP and IPV). However it should not be used for adolescents or adults. The information on this document applies to pediatric use of the vaccines. Risk factors that apply only to older persons, for example, are not discussed on this VIS. The individual VISs should be used.
A: Yes, as long as the doses are given to children as part of the primary series or routine pediatric boosters.
A: It was designed with pneumocococcal conjugate vaccines specifically in mind. For PPSV23, use the pneumococcal polysaccharide VIS.
A: Possibly. If this VIS becomes popular with providers, we would like to develop multi-vaccine VISs for other situations in which several vaccines are administered at the same visit.